Short immunomodulatory oligonucleotides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 14, 2010
Grant Date -
Jan 8, 2009
app pub date -
Oct 24, 2007
filing date -
Feb 7, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to modulation of the immune system. More particularly, the invention relates to modulating the immune system through the use of oligonucleotide-derived compounds. The invention provides immunostimulatory agents that are less expensive to make than existing immunostimulatory oligonucleotides. The immunostimulatory agents according to the invention can, in preferred embodiments, cause immune stimulation across species lines.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully